09.28.21
Arkema announces the proposed divestment of its epoxides business to Cargill. With this project, Arkema is pursuing the repositioning of its portfolio on its core businesses.
Arkema produces bio-based and specialty epoxides in Blooming Prairie, MN, used as addi-tives or intermediates in the manufacture of lubricants, plastic additives and a wide varie-ty of other applications. Part of Arkema’s Hydrogen Peroxide activity, this business has limited integration with the rest of the Group’s portfolio, generates sales of around US $40 million and employs approximately 45 people.
By joining Cargill, a global player in bio-based-products, this business of high quality products will benefit from the size and the development strategy of this US group that will offer new growth potential in the industrial markets.
The offer received values this activity at US $38.8 million, which is around 10 times histor-ical EBITDA.
The deal is expected to close in the fourth quarter of 2021.
Arkema produces bio-based and specialty epoxides in Blooming Prairie, MN, used as addi-tives or intermediates in the manufacture of lubricants, plastic additives and a wide varie-ty of other applications. Part of Arkema’s Hydrogen Peroxide activity, this business has limited integration with the rest of the Group’s portfolio, generates sales of around US $40 million and employs approximately 45 people.
By joining Cargill, a global player in bio-based-products, this business of high quality products will benefit from the size and the development strategy of this US group that will offer new growth potential in the industrial markets.
The offer received values this activity at US $38.8 million, which is around 10 times histor-ical EBITDA.
The deal is expected to close in the fourth quarter of 2021.